Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 - A prospective study

56Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Trastuzumab, a recombinant humanized monoclonal antibody, is targeted against the external domain of the human epidermal growth factor receptor type 2 (HER2). It improves efficacy of HER2-positive breast cancer treatment. The authors present their experience with patients (pts) treated with trastuzumab in the aspects of cardiac complications. Material and methods: We observed prospectively 253 women with early positive HER2 breast cancer treated with trastuzumab. Assessment of cardiovascular status, ECG and echocardiography was performed initially and every 3 months until 6 th month during follow-up. Results: Cardiac complications developed in 52 pts (20.55%) and included: asymptomatic left ventricle dysfunction (43), symptomatic heart failure (6), new asymptomatic LBBB (1); new negative T-waves in ECG (2). There was a progressive decline in left ventricular ejection fraction (LVEF) during treatment. It was more enhanced in pts with cardiac complications. Following trastuzumab termination/discontinuation LVEF increased but at month 18 still remained significantly lower than initially in both groups (61.07 ±4.84 vs. 59.97 ±5.23 - no cardiac complications; p < 0.05; 58.14 ±4.08% vs. 53.08 ±5.74% - cardiac complications; p < 0.05). During 6-month follow-up 33 out of 46 pts experienced an improvement in left ventricular status. In 13 pts in whom trastuzumab was discontinued, it was restarted; 6 of them successfully completed total therapy. Univariate analysis revealed no association between any cardiovascular risk factor and the development of cardiotoxicity. Conclusions: One out of five treated patients discontinues trastuzumab in an adjuvant setting due to cardiac complications. LV dysfunction is the most frequent. Routine cardiac monitoring should be obligatory. Copyright © 2012 Termedia & Banach.

References Powered by Scopus

Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene

10695Citations
N/AReaders
Get full text

Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology

10016Citations
N/AReaders
Get full text

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults

6490Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cardiovascular toxicity associated with adjuvant trastuzumab therapy: Prevalence, patient characteristics, and risk factors

100Citations
N/AReaders
Get full text

Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer

83Citations
N/AReaders
Get full text

Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer

73Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Piotrowski, G., Gawor, R., Stasiak, A., Gawor, Z., Potemski, P., & Banach, M. (2012). Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 - A prospective study. Archives of Medical Science, 8(2), 227–235. https://doi.org/10.5114/aoms.2012.28549

Readers over time

‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

73%

Researcher 6

23%

Professor / Associate Prof. 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

73%

Agricultural and Biological Sciences 4

13%

Psychology 2

7%

Biochemistry, Genetics and Molecular Bi... 2

7%

Save time finding and organizing research with Mendeley

Sign up for free
0